</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
CB Partner Webinar {{webinarsautomatedemailsthankyou::omeda}} #EVENTTITLE# {{webinarsautomatedemailsthankyou::round_table}} ElleVet Sciences {{webinarsautomatedemailsthankyou::client_only_logo}} {{webinarsautomatedemailsthankyou::client_only_logo_self_hosted}} {{webinarsautomatedemailsthankyou::client_only_logo_alt}} {{webinarsautomatedemailsthankyou::client_only_logo_width}} {{webinarsautomatedemailsthankyou::client_only_logo_custom_css}} {{webinarsautomatedemailsthankyou::client_color}} {{webinarsautomatedemailsthankyou::supported_by}} We hope the information was valuable in understanding the potential applications of CBD in patients with OA and neuropathic pain. Neuropathic pain can be hard to diagnose but is important to identify and treat in dogs and cats. In humans, only half of the patients with neuropathic pain find partial relief. The numbers are likely much worse in animals. In neuropathic pain, the peripheral nerves drive all changes in the “pain sensing system,” leading to neurogenic inflammation. This type of pain often causes behavior changes due to abnormal sensations (eg, allodynia), which should increase suspicion of pain and warrant treatment. If neuropathic pain is suspected, trial therapy is recommended. Several classes of drugs, including tricyclic antidepressants, gabapentin, amantadine, and topicals such as lidocaine, may be effective, as can acupuncture. Studies support the potential of CBD/CBDA products for treating neuropathic pain and osteoarthritis. Hemp-derived cannabinoids are legal at the federal level, but state regulations vary. Protect yourself and your patients by using products that have pharmacokinetic data, safety and efficacy studies from more than one laboratory, and a full Certificate of Analysis. Not all hemp compounds are the same, and products may contain a wide variety of compounds. A full-spectrum hemp product that fits the previously mentioned criteria is more likely to be effective. Acidic cannabinoids (eg, CBDA) show superior absorption and retention over decarboxylated forms (eg, CBD).

Download a printable PDF of these takeaways.

{{webinarsautomatedemailsthankyou::printable_pdf_url}}

Please note that a minimum of 50 minutes worth of attendance during the live event was required to receive your certificate. If you did not download your CE certificate during the event, click here to download your certificate.

{{webinarsautomatedemailsthankyou::ce_certificate_url}} #AUDIENCEURL# true
Dear #FIRSTNAME#,
Thank you for attending our webinar, "#EVENTTITLE#," sponsored by ElleVet Sciences. We hope the information was valuable in understanding the potential applications of CBD in patients with OA and neuropathic pain. Thank you for attending our webinar, "#EVENTTITLE#." We hope the information was valuable in understanding the potential applications of CBD in patients with OA and neuropathic pain.
Below you will find the Top 5 Takeaways from the webinar.
Top 5 Takeaways
  1. Neuropathic pain can be hard to diagnose but is important to identify and treat in dogs and cats. In humans, only half of the patients with neuropathic pain find partial relief. The numbers are likely much worse in animals.
  2. In neuropathic pain, the peripheral nerves drive all changes in the “pain sensing system,” leading to neurogenic inflammation. This type of pain often causes behavior changes due to abnormal sensations (eg, allodynia), which should increase suspicion of pain and warrant treatment.
  3. If neuropathic pain is suspected, trial therapy is recommended. Several classes of drugs, including tricyclic antidepressants, gabapentin, amantadine, and topicals such as lidocaine, may be effective, as can acupuncture. Studies support the potential of CBD/CBDA products for treating neuropathic pain and osteoarthritis.
  4. Hemp-derived cannabinoids are legal at the federal level, but state regulations vary. Protect yourself and your patients by using products that have pharmacokinetic data, safety and efficacy studies from more than one laboratory, and a full Certificate of Analysis.
  5. Not all hemp compounds are the same, and products may contain a wide variety of compounds. A full-spectrum hemp product that fits the previously mentioned criteria is more likely to be effective. Acidic cannabinoids (eg, CBDA) show superior absorption and retention over decarboxylated forms (eg, CBD).

Download a printable PDF of these takeaways.
Your CE Certificate

Please note that a minimum of 50 minutes worth of attendance during the live event was required to receive your certificate. If you did not download your CE certificate during the event, click here to download your certificate.
Feel free to pass this along to colleagues who may be interested.
If you would like to reference the on‑demand version of the event, click here.
Thanks again for attending,
The Clinician's Brief Team
The ElleVet Sciences Team
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
Dear #FIRSTNAME#,
Thank you for attending our webinar, "#EVENTTITLE#," sponsored by ElleVet Sciences. We hope the information was valuable in understanding the potential applications of CBD in patients with OA and neuropathic pain. Thank you for attending our webinar, "#EVENTTITLE#." We hope the information was valuable in understanding the potential applications of CBD in patients with OA and neuropathic pain.
Below you will find the Top 5 Takeaways from the webinar.
Top 5 Takeaways
  1. Neuropathic pain can be hard to diagnose but is important to identify and treat in dogs and cats. In humans, only half of the patients with neuropathic pain find partial relief. The numbers are likely much worse in animals.
  2. In neuropathic pain, the peripheral nerves drive all changes in the “pain sensing system,” leading to neurogenic inflammation. This type of pain often causes behavior changes due to abnormal sensations (eg, allodynia), which should increase suspicion of pain and warrant treatment.
  3. If neuropathic pain is suspected, trial therapy is recommended. Several classes of drugs, including tricyclic antidepressants, gabapentin, amantadine, and topicals such as lidocaine, may be effective, as can acupuncture. Studies support the potential of CBD/CBDA products for treating neuropathic pain and osteoarthritis.
  4. Hemp-derived cannabinoids are legal at the federal level, but state regulations vary. Protect yourself and your patients by using products that have pharmacokinetic data, safety and efficacy studies from more than one laboratory, and a full Certificate of Analysis.
  5. Not all hemp compounds are the same, and products may contain a wide variety of compounds. A full-spectrum hemp product that fits the previously mentioned criteria is more likely to be effective. Acidic cannabinoids (eg, CBDA) show superior absorption and retention over decarboxylated forms (eg, CBD).

Download a printable PDF of these takeaways.
Your CE Certificate

Please note that a minimum of 50 minutes worth of attendance during the live event was required to receive your certificate. If you did not download your CE certificate during the event, click here to download your certificate.
Feel free to pass this along to colleagues who may be interested.
If you would like to reference the on‑demand version of the event, click here.
Thanks again for attending,
The Clinician's Brief Team
The ElleVet Sciences Team